These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 24696098)

  • 21. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.
    Casey JR; Adlowitz DG; Pichichero ME
    Pediatr Infect Dis J; 2010 Apr; 29(4):304-9. PubMed ID: 19935445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008-2019).
    Macaj M; Perdochova L; Jakubikova J
    Vaccine; 2023 Jan; 41(2):452-459. PubMed ID: 36470684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic Review.
    Marra LP; Sartori AL; Martinez-Silveira MS; Toscano CM; Andrade AL
    Value Health; 2022 Jun; 25(6):1042-1056. PubMed ID: 35667776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of acute otitis media in children in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018.
    Hu T; Done N; Petigara T; Mohanty S; Song Y; Liu Q; Lemus-Wirtz E; Signorovitch J; Sarpong E; Weiss T
    BMC Infect Dis; 2022 Mar; 22(1):294. PubMed ID: 35346092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.
    Veenhoven R; Bogaert D; Uiterwaal C; Brouwer C; Kiezebrink H; Bruin J; IJzerman E; Hermans P; de Groot R; Zegers B; Kuis W; Rijkers G; Schilder A; Sanders E
    Lancet; 2003 Jun; 361(9376):2189-95. PubMed ID: 12842372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.
    Leach AJ; Wigger C; Hare K; Hampton V; Beissbarth J; Andrews R; Chatfield M; Smith-Vaughan H; Morris PS
    BMC Pediatr; 2015 Oct; 15():162. PubMed ID: 26482232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of pneumococcal conjugated vaccines on occurrence of recurrent acute otitis media among infants diagnosed with acute otitis media at an age younger than 2 months.
    Ziv O; Adelson D; Sadeh R; Kordeluk S; El-Saied S; Leibovitz E; Kraus M; Kaplan D
    Eur J Pediatr; 2023 Jun; 182(6):2873-2879. PubMed ID: 37052673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Effectiveness of the PCV-10 and PCV-13 Vaccines Against Invasive Pneumococcal Disease.
    Berman-Rosa M; O'Donnell S; Barker M; Quach C
    Pediatrics; 2020 Apr; 145(4):. PubMed ID: 32156773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England.
    Mohanty S; Podmore B; Cuñado Moral A; Weiss T; Matthews I; Sarpong E; Méndez I; Qizilbash N
    BMC Public Health; 2023 Jan; 23(1):201. PubMed ID: 36717794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotics for preventing acute otitis media in children.
    Scott AM; Clark J; Julien B; Islam F; Roos K; Grimwood K; Little P; Del Mar CB
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012941. PubMed ID: 31210358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xylitol for preventing acute otitis media in children up to 12 years of age.
    Azarpazhooh A; Lawrence HP; Shah PS
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD007095. PubMed ID: 27486835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review.
    Boonacker CW; Broos PH; Sanders EA; Schilder AG; Rovers MM
    Pharmacoeconomics; 2011 Mar; 29(3):199-211. PubMed ID: 21250759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xylitol for preventing acute otitis media in children up to 12 years of age.
    Azarpazhooh A; Limeback H; Lawrence HP; Shah PS
    Cochrane Database Syst Rev; 2011 Nov; (11):CD007095. PubMed ID: 22071833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Otitis media sequelae and hearing in adolescence after administration of an 11-valent conjugate pneumococcal vaccine in infancy: a prospective cohort study with long-term follow-up of the ARIVAC trial.
    Simões EAF; Carosone-Link P; Sanvictores DM; Uhler KM; Lucero M; Tallo V; Chan KH
    Lancet Child Adolesc Health; 2024 Sep; 8(9):647-655. PubMed ID: 39096922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of pneumococcal conjugate vaccines on acute otitis media in Japan.
    Sasaki A; Kunimoto M; Takeno S; Sumiya T; Ishino T; Sugino H; Hirakawa K
    Auris Nasus Larynx; 2018 Aug; 45(4):718-721. PubMed ID: 29102419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions.
    Edmondson-Jones M; Dibbern T; Hultberg M; Anell B; Medin E; Feng Y; Talarico C
    Hum Vaccin Immunother; 2021 Feb; 17(2):517-526. PubMed ID: 32574101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.
    Leach AJ; Wigger C; Beissbarth J; Woltring D; Andrews R; Chatfield MD; Smith-Vaughan H; Morris PS
    Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():224-32. PubMed ID: 27260611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study.
    Pichichero M; Kaur R; Scott DA; Gruber WC; Trammel J; Almudevar A; Center KJ
    Lancet Child Adolesc Health; 2018 Aug; 2(8):561-568. PubMed ID: 30119715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
    Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
    Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.